-
AACR Scientist↔Survivor Program: The Patient Perspective
In a sea of p-values and distribution curves, patient advocates and survivors at a scientific gathering remind researchers who is behind the numbers.
by Marci A. Landsmann
-
Immunotherapy Combinations
Researchers are combining immunotherapies with each other and with other treatments in hopes that a larger proportion of patients will have long-term benefits.
by Kate Yandell
-
Patient Advocates Go to Washington
Patient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.
by Marci A. Landsmann
-
The Affordable Care Act and Cancer Patients
Cancer survivors tell their stories and researchers take a broad view.
by Kevin McLaughlin
-
But I Already Have Cancer
For a patient with advanced cancer, how important is screening for other types of cancer?
by Ide Mills
-
Integrative Strategies for Facing Cancer
Brain tumor survivor uses her experiences to help others.
by Jeannine Walston
-
Biden Calls for Collaboration
Vice president cites immunotherapy, big data and team science as innovative ways to speed progress against cancer.
by Kevin McLaughlin
Previous |
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore